Yahoo · Nov 24, 2025
Haw Par (SGX:H02) Ticks All The Boxes When It Comes To Earnings Growth
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
HA
OTC · HAWPY
Haw Par Corporation Limited
Healthcare · Drug Manufacturers - General
$53.50
Up+$0.00 (+0.00%)
Updated Oct 14, 2026, 3:14 AM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 2.81B
- P/E ratio
- 13.87
- Dividend yield
- 8.10%
- 52-week range
- — – —
- Volume
- 7
- Avg. volume
- 2
Price performance · HAWPY
HAWPY price history
1M range · 0 trading sessions · Daily adjusted prices
HAWPY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest HAWPY news
The latest Smart Investors Daily articles mentioning HAWPY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HAWPY research
Overview
Company profile and research snapshot.
Company profile
HAW PAR CORP LTD UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
